Improving Neck and Jawline Aesthetics With OnabotulinumtoxinA by Minimizing Platysma Muscle Contraction Effects: Efficacy and Safety Results in a Phase 3 Randomized, Placebo-Controlled Study
Aesthetic Surgery Journal · 2025
DOI: 10.1093/asj/sjae220 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Aesthetic Surgery Journal, 2025. Verfasst von Sachin M Shridharani und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Muscle Contraction, Neuromuscular Agents, Skin Aging. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Allergan Aesthetics, AbbVie company.
Abstract (Originalsprache)
Background
Platysma prominence (PP) describes the noticeable appearance of the platysma muscle upon contraction, causing a less defined jawline contour and vertical neck bands.
Objectives
The objective of this study was to assess the safety and efficacy of onabotulinumtoxinA for improvement of PP in adults.
Methods
Participants with moderate to severe (Grade 3 to 4) PP at maximum contraction received onabotulinumtoxinA or placebo on Day 1 and were monitored for 120 days. OnabotulinumtoxinA dosage (26, 31, or 36 U) was customized based on baseline PP severity on each side of the neck.
Results
Efficacy analyses were conducted in the intent-to-treat (ITT) population (all randomized participants), and modified ITT population (mITT; psychosocially impacted by PP appearance). Results from ITT and mITT populations were comparable. As assessed by investigators, 76.7% of onabotulinumtoxinA mITT participants achieved ≥1-grade improvement vs 21.2% in the placebo group, and 41.0% vs 2.2% (P < .0001) achieved ≥2-grade improvement at Day 14. As assessed by participants, 79.9% of onabotulinumtoxinA mITT participants vs 21.8% in the placebo group and 40.8% vs 3.9% (P < .0001) achieved ≥1- or ≥2-grade improvement, respectively, at Day 14. OnabotulinumtoxinA responder rates remained higher than placebo through Day 120, gradually declining over time. OnabotulinumtoxinA participants reported significantly higher satisfaction with treatment effect, less bother from jawline and vertical neck bands, and lower psychosocial impact from PP than placebo at Day 14 (P < .0001). OnabotulinumtoxinA effectively improved self-perceived jawline definition and was well tolerated.
Conclusions
OnabotulinumtoxinA was well tolerated and effective at improving moderate to severe PP, including neck bands and jawline definition. Level of Evidence: 1 (Therapeutic)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- Allergan Aesthetics
- AbbVie company
Zitieren
APA
Shridharani, S. M., Ogilvie, P., Couvillion, M., Pavicic, T., Lain, E., Jierjian, E., Lee, E., Park, G. S., Shimoga, S., Tong, W., & Hopfinger, R. (2025). Improving Neck and Jawline Aesthetics With OnabotulinumtoxinA by Minimizing Platysma Muscle Contraction Effects: Efficacy and Safety Results in a Phase 3 Randomized, Placebo-Controlled Study. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjae220
Vancouver
Shridharani SM, Ogilvie P, Couvillion M, Pavicic T, Lain E, Jierjian E, et al. Improving Neck and Jawline Aesthetics With OnabotulinumtoxinA by Minimizing Platysma Muscle Contraction Effects: Efficacy and Safety Results in a Phase 3 Randomized, Placebo-Controlled Study. Aesthetic Surgery Journal. 2025. doi:10.1093/asj/sjae220
BibTeX
@article{Shridharani2025,
author = {Shridharani, Sachin M and Ogilvie, Patricia and Couvillion, Megan and Pavicic, Tatjana and Lain, Edward and Jierjian, Edward and Lee, Elisabeth and Park, Grace S and Shimoga, Sandhya and Tong, Warren and Hopfinger, René},
title = {Improving Neck and Jawline Aesthetics With OnabotulinumtoxinA by Minimizing Platysma Muscle Contraction Effects: Efficacy and Safety Results in a Phase 3 Randomized, Placebo-Controlled Study},
journal = {Aesthetic Surgery Journal},
year = {2025},
doi = {10.1093/asj/sjae220}
}
EUVIMED